The research aims to assess the occurrence of second primary malignancies (SPMs) in long-term survivors of unresectable esophageal cancer.
Assessment of long-term survivors of unresectable esophageal cancer.
Monitoring for the development of second primary malignancies after initial treatment.
Analysis of post-treatment outcomes related to SPM occurrences.
Long-term survivors exhibit a measurable incidence of second primary malignancies.
The findings underscore the necessity for continuous post-treatment surveillance for SPMs.
Resumen
Even among patients with unresectable esophageal cancer, long-term survivors had a measurable rate of SPMs. This highlights the importance of post-treatment surveillance for SPMs.